PPSCFPSCNTSPakistan govt jobs
- Subject
- A.N.S, Blood And Endocrinal Drugsmedical-mcqs › pharmacology › a-n-s-blood-and-endocrinal-drugs
- Published
- 28 Jul 2019
- Last updated
- 28 May 2026
Explanation
D-tubocurarine acts as a competitive antagonist at nicotinic acetylcholine receptors on the motor end plate, thereby blocking acetylcholine from binding and preventing muscle contraction. It does not affect acetylcholine release, degrade acetylcholine, or inhibit acetylcholinesterase.
More A.N.S, Blood And Endocrinal Drugs MCQs
Practice related questions from the same subject.
- 1.What effects can indirect sympathomimetic drugs produce?
- 2.What is the primary therapeutic effect of glucocorticoids?
- 3.A patient presents with symptoms including bronchodilation, elevated body temperature, constipation, and rapid heart rate. What is the most likely diagnosis?
- 4.Identify the drug that does NOT belong to the second-generation antihistamines.
- 5.Which of the following glucocorticoids is NOT administered via inhalation?
- 6.Which of the following is NOT a mechanism by which sulfonylureas exert their effect?
- 7.Which of the following statements about nitric oxide is INCORRECT?
- 8.What type of medication is clopidogrel classified as?